Tetraphase Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TTPH Nasdaq 8731 https://www.tphase.com/ 8.30 Stock Up +0.43

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tetraphase Pharmaceuticals Inc

Tetraphase Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : TTPH-US : July 21, 2017 - Jul 21st, 2017 6:35 am
ETFs with exposure to Tetraphase Pharmaceuticals, Inc. : July 14, 2017 - Jul 14th, 2017 3:17 pm
Implied Volatility Surging for Tetraphase Pharmaceuticals (TTPH) Stock Options - Jul 3rd, 2017 6:46 am
Tetraphase Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : TTPH-US : June 22, 2017 - Jun 22nd, 2017 6:07 am
ETFs with exposure to Tetraphase Pharmaceuticals, Inc. : June 5, 2017 - Jun 5th, 2017 12:52 pm
Tetraphase Pharmaceuticals Announces Positive Phase 1 Single-Ascending Dose Data for Antibiotic Pipeline Candidates - Jun 5th, 2017 6:00 am
Tetraphase Pharmaceuticals, Inc. :TTPH-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 - Jun 2nd, 2017 7:49 am
Tetraphase Pharmaceuticals to Present at Jefferies 2017 Global Healthcare Conference - May 30th, 2017 6:00 am
Tetraphase Pharmaceuticals to Present Antibiotics Pipeline Data at ASM Microbe 2017 - May 22nd, 2017 6:00 am
Tetraphase Pharmaceuticals, Inc. – Value Analysis (NASDAQ:TTPH) : May 15, 2017 - May 15th, 2017 3:27 pm
Tetraphase Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : TTPH-US : May 12, 2017 - May 12th, 2017 6:14 am
Tetraphase reports 1Q loss - May 5th, 2017 3:03 am
Tetraphase Pharmaceuticals Reports First Quarter 2017 Financial Results and Reviews Recent Highlights - May 4th, 2017 2:05 pm
​These 5 Mass. biotechs are getting $12M to fight ‘superbugs’ - Mar 31st, 2017 10:35 am
ETFs with exposure to Tetraphase Pharmaceuticals, Inc. : March 27, 2017 - Mar 27th, 2017 2:08 pm